Keeping Current CME Medscape
-
- Health & Fitness
-
Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.
-
Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer
How do you define high-risk for recurrence in breast cancer?
Credit available for this activity expires: [03/27/25]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000352?ecd=bdc_podcast_libsyn_mscpedu
-
What You Always Wanted to Know About Obesity but Never Dared to Ask: Quick Questions and Rapid Replies
Do you recognize obesity as a biological disease that requires long-term intervention and management?
Credit available for this activity expires: 3/25/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000368?ecd=bdc_podcast_libsyn_mscpedu -
Harm Reduction From Tobacco: An Evidence-Based Discussion
How much risk is associated with different tobacco products? Drs Satel and Rodu discuss.
Credit available for this activity expires: 3/27/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000537?ecd=bdc_podcast_libsyn_mscpedu -
Selecting Therapies to Optimize Treatment Success in Schizophrenia
What factors should be considered when initiating maintenance therapy for schizophrenia?
Credit available for this activity expires: [03/26/25]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000520?ecd=bdc_podcast_libsyn_mscpedu -
Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations
Are you aware that molecular testing is necessary to inform the appropriate adjuvant treatment decision for patients?
Credit available for this activity expires: 3/22/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000409?ecd=bdc_podcast_libsyn_mscpedu -
Which Endpoints Matter Most in Transthyretin Amyloid Cardiomyopathy Trials? Are We Comparing Apples to Apples?
Do you know how to interpret the results of recent phase 3 clinical trials in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)?
Credit available for this activity expires: 3/22/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000444?ecd=bdc_podcast_libsyn_mscpedu